Ilan Oren - 17 Apr 2026 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Reporting relationship: Director
Issuer ticker: ROIV
Reported as of: 17 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Apr 2026, 21:00:45 UTC
Prior SEC filing: 22 Jan 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Jo Chen, as Attorney-in-Fact for Ilan Oren

Key filing fact

Ilan Oren filed Form 4 for Roivant Sciences Ltd. (ROIV) on 21 Apr 2026.

Key facts

This page summarizes Ilan Oren's Form 4 filing for Roivant Sciences Ltd. (ROIV).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 21 Apr 2026, 21:00.

Change

Previous filing in this sequence was filed on 22 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001643073 Primary reporting owner

Oren Ilan

Relationship: Director
Address: C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Ilan Oren
Signature date: 21 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ROIV transaction

Common Shares

Award

Transaction value
Shares: +896
Change %: +0.75%
Price: $0.000000^*
Shares after: 120,324
Date: 17 Apr 2026
Ownership: Direct
Footnotes: F1

ROIV transaction

Common Shares

Tax liability

Transaction value
Shares: -95
Change %: -0.08%
Price: $29.83^*
Shares after: 120,229
Date: 17 Apr 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.

Footnote F2

Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.